In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer. In an interview with CURE, Dr. David A. Taub ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...
If you have been diagnosed with advanced prostate cancer, it's important to understand your treatment options. Your doctor will work with you to choose the optimal treatment approach. Your doctor can ...
Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...
A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...
An estimated 1 in 8 men will be diagnosed with prostate cancer in their lifetime, often after 65. And as terrifying as that number is, a diagnosis isn’t always quite what it seems. Today, the vast ...
If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...
Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani: Shardul Nautiyal, Mumbai ...
Former US President Joe Biden has been diagnosed with “aggressive” prostate cancer and is reviewing treatment options with his doctors. His office confirmed the news as the 46th US President was ...
In other news tonight, former President Biden's office has announced that he's been diagnosed with an aggressive form of prostate cancer. The cancer spread to the bone and Mr. Biden and his family are ...